Tinabinol
 | |
| Clinical data | |
|---|---|
| ATC code | None |
| Identifiers | |
| |
| CAS Number | 50708-95-7 |
| PubChem (CID) | 65443 |
| ChemSpider | 58905 |
| Chemical and physical data | |
| Formula | C23H34O2S |
| Molar mass | 374.580 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
Tinabinol (INN; SP-119) is a synthetic cannabinoid drug and analogue of dronabinol which was patented as an antihypertensive but was never marketed.[1][2]
See also
References
- ↑ David T. Brown (19 November 1998). Cannabis: The Genus Cannabis. CRC Press. p. 80. ISBN 978-90-5702-291-3. Retrieved 27 April 2012.
- ↑ Martin Negwer (1994). Organic-chemical drugs and their synonyms: an international survey. Indices. Akad.-Verl. p. 2242. ISBN 978-3-05-501629-5. Retrieved 27 April 2012.
| Receptor (ligands) |
| ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Transporter (modulators) |
| ||||||||||||||||||
| Enzyme (modulators) |
| ||||||||||||||||||
| Others |
| ||||||||||||||||||
| |||||||||||||||||||
This article is issued from Wikipedia - version of the 10/20/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.